Award
U.S. Department of Veterans Affairs Southeast Louisiana Health Care System 5I01BX005633-04
Polymorphic L1 transposons as a Genetic Variable Distinguishing Aggressive from Indolent Prostate Cancer
Recipient
Southeast Louisiana Veterans Health Care
Awarded
January 20, 2026
Identifier
5I01BX005633-04
This award funds research to identify genetic biomarkers for aggressive prostate cancer in Veterans, focusing on polymorphic L1 retrotransposons to develop predictive genetic tests.
Description
Research project to establish new biomarkers and develop genetic tests to predict and distinguish aggressive prostate cancer, especially in Veterans, to improve health outcomes. The study focuses on polymorphic L1 retrotransposons (pL1s) as predictive biomarkers enriched in genomes of patients with metastatic prostate cancer, aiming to create reliable genetic tests for early identification of high-risk men.